RB1 and neoplasm: In addition, one primary tumor (A12) exhibited a subclonal RB1 mutation [cancer cell fraction (CCF) 71%] with a corresponding subclonal loss of pRb expression by IHC in ∼70% of the tumor cross-sectional area.